CVS Health’s fair value estimate has been updated from about US$94.84 to roughly US$96.38 per share, a small adjustment that still matters if you are tracking the name closely. This change sits ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...

CVS Health Corporation (NYSE:CVS) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 12, Bernstein raised the firm’s price target on CVS Health Corporation (NYSE:CVS) to ...

CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy now. On November 3, 2025, TD Cowen lifted its price target on the stock to $100 from $99, while keeping a Buy rating. The ...

Fintel reports that on March 12, 2026, Bernstein upgraded their outlook for CVS Health (NYSE:CVS) from Market Perform to Outperform. Analyst Price Forecast Suggests 26.44% Upside As of February 25, ...

Their corporate logos share colors, their aisles share similar products — and now they’ll share floor space. Despite the similarities between their businesses, CVS Health CEO Larry Merlo and Target ...

Drugstore operator CVS Health Corp said it will acquire Target Corp’s U.S. pharmacy and clinics businesses for about $1.9 billion to boost sales and prescription volumes. CVS said it will acquire more ...

MYRTLE BEACH, S.C. (NEXSTAR) — Target and CVS announced a partnership Wednesday that will allow CVS to administer the COVID-19 vaccine to people at CVS pharmacies located within Target stores. This ...